Management of metastatic kidney cancer
This e-course will show the latest indications for the medical treatment of metastatic renal cell carcinoma (RCC) according to the evidence showed in literature and at the ASCO GU 2023 congress.
| Organiser | European School of Urology |
|---|---|
| CME | 1 |
| Duration | Approx. 60 minutes |
Lectures will highlight the first-line and second-line treatment in this stage of the disease. The last part of the e-course will focus on the clinical management of adverse events following systemic treatment in metastatic RCC.
CME: This e-course is accredited with 1 European CME credit (ECMEC®) upon completion.
Acknowledgment
This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.